title: Reply to: "Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma".
authors.affiliation: The Hepato-Oncology Group, Gastro-Intestinal Surgery, Liver Transplantation and Hepatology - Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Sposito
authors.affiliation: The Hepato-Oncology Group, Gastro-Intestinal Surgery, Liver Transplantation and Hepatology - Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy. Electronic address: vincenzo.mazzaferro@istitutotumori.mi.it.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Mazzaferro
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000627:therapeutic use*
chemical_list: D010671:Phenylurea Compounds; D009536:Niacinamide